E-LIB Suche - Ergebnisse für: Sá, MJ

1

POSA44 The Societal Impact of Multiple Sclerosis in France:..:

Bouleau, A ; Schwerer, CA ; Dulong, C...
Value in Health. 25 (2022) 1 - p. S41 , 2022

Link: https://doi.org/10.1016/..

2

POSA292 MSCopilot® as a Digital Tool to Collect Patients' I..:

Dulong, C. ; Brochu, T. ; Delgrange, R....
Value in Health. 25 (2022) 1 - p. S191-S192 , 2022

Link: https://doi.org/10.1016/..

3

The socioeconomic impact of multiple sclerosis in France: R..:

Bouleau, A ; Dulong, C ; Schwerer, CA...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8 (2022) 2 - p. 205521732210932 , 2022

Link: https://doi.org/10.1177/..

4

Neuromyelitis optica spectrum disorders: A nationwide Portu..:

Santos, E ; Rocha, AL ; Oliveira, V...
Mult Scler Relat Disord . 2021 Nov;56:103258.. , 2023

Link: http://hdl.handle.net/10..

5

Consensus for the Early Identification of Secondary Progres..:

Sá, MJ ; Basílio, C ; Capela, C...
Acta Med Port . 2023;36(3):167-173.. , 2023

Link: http://hdl.handle.net/10..

6

Application of diagnostic criteria for optic neuritis – Aut..:

Petzold, A ; Liu, Y ; Fraser, C...
https://discovery.ucl.ac.uk/id/eprint/10181221/12/Petzold_response-RAPD-accepted-version.pdf. , 2023

Link: https://discovery.ucl.ac..

7

Late Onset Neuromyelitis Optica Spectrum Disorders (LONMOSD..:

Santos, E ; Moura, J ; Samões, R...
Mult Scler Relat Disord . 2022 Jul;63:103845.. , 2022

Link: http://hdl.handle.net/10..

8

The socioeconomic impact of multiple sclerosis in France: R..:

Bouleau, A ; Dulong, C ; Schwerer, CA...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036344/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Neuromyelitis Optica Spectrum Disorders: a Nationwide Portu..:

Santos, E ; Rocha, AL ; Oliveira, V...
Mult Scler Relat Disord. 2021 Nov;56:103258.. , 2021

Link: http://hdl.handle.net/10..

10

Neuromyelitis optica spectrum disorders: A nationwide Portu..:

Santos, E ; Rocha, AL ; Oliveira, V...
Mult Scler Relat Disord. 2021;56: 103258. , 2021

Link: http://hdl.handle.net/10..

11

Multiple sclerosis, disease-modifying therapies and COVID-1..:

Cabreira, V ; Abreu, P ; Soares-Dos-Reis, R..
Vaccines, vol.9(7):773. , 2021

Link: https://hdl.handle.net/1..

12

The epidemiology of multiple sclerosis in the entre Douro e..:

Branco, M ; Alves, I ; Martins, de Silva, A...
BMC Neurol. 2020 May 19;20(1):195. doi:10.1186/s12883-020-01755-8. , 2020

Link: https://hdl.handle.net/1..

13

A Multicenter, Non-Interventional Study to Evaluate the Dis..:

Ladeira, F ; Braz, L ; Salgado, P...
Clin Neurol Neurosurg. 2019 Sep;184:105390.. , 2019

Link: http://hdl.handle.net/10..

14

Genomic imbalances defining novel intellectual disability a..:

Lopes, F ; Torres, F ; Soares, G...
info:eu-repo/grantAgreement/FCT/5876-PPCDTI/83026/PT. , 2019

Link: https://hdl.handle.net/1..

15

International consensus on quality standards for brain heal..:

Hobart, J ; Bowen, A ; Pepper, G...
issn:1352-4585. , 2019

Link: http://hdl.handle.net/11..